Lista de obras - Martine Lamfers - Dominio Público Uruguay

ABT-888 enhances cytotoxic effects of temozolomide independent of MGMT status in serum free cultured glioma cells.

artículo científico publicado en 2015

AdDelta24 and the p53-expressing variant AdDelta24-p53 achieve potent anti-tumor activity in glioma when combined with radiotherapy.

artículo científico publicado en 2007

Adenoviral delivery of a constitutively active retinoblastoma mutant inhibits neointima formation in a human explant model for vein graft disease

artículo científico publicado en 2002

Adenoviral expression of a urokinase receptor-targeted protease inhibitor inhibits neointima formation in murine and human blood vessels.

artículo científico publicado en 2001

Anatomical differences determine distribution of adenovirus after convection-enhanced delivery to the rat brain

artículo científico publicado en 2011

Characterization of infectivity of knob-modified adenoviral vectors in glioma.

artículo científico publicado en 2008

Complement activation in Glioblastoma multiforme pathophysiology: evidence from serum levels and presence of complement activation products in tumor tissue

artículo científico publicado en 2014

Conditionally replicative adenovirus expressing a targeting adapter molecule exhibits enhanced oncolytic potency on CAR-deficient tumors.

artículo científico publicado en 2003

Coronavirus genetically redirected to the epidermal growth factor receptor exhibits effective antitumor activity against a malignant glioblastoma

artículo científico publicado en 2009

Cyclophosphamide increases transgene expression mediated by an oncolytic adenovirus in glioma-bearing mice monitored by bioluminescence imaging

artículo científico publicado en 2006

DNA Methylation and Somatic Mutations Converge on the Cell Cycle and Define Similar Evolutionary Histories in Brain Tumors

artículo científico publicado en 2015

DNA damage response and anti-apoptotic proteins predict radiosensitization efficacy of HDAC inhibitors SAHA and LBH589 in patient-derived glioblastoma cells.

artículo científico publicado en 2014

Delta-24-RGD oncolytic adenovirus elicits anti-glioma immunity in an immunocompetent mouse model

artículo científico publicado en 2014

Differential effects of combined Ad5- delta 24RGD and radiation therapy in in vitro versus in vivo models of malignant glioma.

artículo científico publicado en 2007

Distinguishing inflammation from tumor and peritumoral edema by myeloperoxidase magnetic resonance imaging.

artículo científico publicado en 2011

Establishing the Lysine-rich Protein CEST Reporter Gene as a CEST MR Imaging Detector for Oncolytic Virotherapy

artículo científico publicado en 2015

Evaluation of adenoviral oncolytic effect on glioma spheroids by 18F-DG positron-emission tomography

artículo científico publicado en 2007

Evolution of DNA repair defects during malignant progression of low-grade gliomas after temozolomide treatment

artículo científico publicado en 2015

Evolving gene therapy approaches for osteosarcoma using viral vectors: review

artículo científico publicado en 2006

Gene delivery into malignant glioma by infectivity-enhanced adenovirus: in vivo versus in vitro models

artículo científico publicado en 2007

Gene therapy for meningioma: improved gene delivery with targeted adenoviruses

artículo científico publicado en 2002

Gene transfer of the urokinase-type plasminogen activator receptor-targeted matrix metalloproteinase inhibitor TIMP-1.ATF suppresses neointima formation more efficiently than tissue inhibitor of metalloproteinase-1.

artículo científico publicado en 2002

Generation, characterization, and drug sensitivities of 12 patient-derived IDH1-mutant glioma cell cultures

artículo científico publicado en 2021

Genetic biomarkers of drug response for small-molecule therapeutics targeting the RTK/Ras/PI3K, p53 or Rb pathway in glioblastoma.

artículo científico publicado en 2016

Glioblastoma-derived extracellular vesicles modify the phenotype of monocytic cells.

artículo científico publicado en 2015

Heterogeneous reovirus susceptibility in human glioblastoma stem-like cell cultures.

artículo científico publicado en 2013

Histone deacetylase inhibitors upregulate expression of the coxsackie adenovirus receptor (CAR) preferentially in bladder cancer cells

artículo científico publicado en 2004

Homing properties of adipose-derived stem cells to intracerebral glioma and the effects of adenovirus infection

artículo científico publicado en 2008

IDH1 R132H decreases proliferation of glioma cell lines in vitro and in vivo

artículo científico publicado en 2011

In vitro screening of clinical drugs identifies sensitizers of oncolytic viral therapy in glioblastoma stem-like cells.

artículo científico publicado en 2015

In vivo suppression of restenosis in balloon-injured rat carotid artery by adenovirus-mediated gene transfer of the cell surface-directed plasmin inhibitor ATF.BPTI.

artículo científico publicado en 2001

Locally-delivered T-cell-derived cellular vehicles efficiently track and deliver adenovirus delta24-RGD to infiltrating glioma

artículo científico publicado en 2014

Neurosurgical delivery of chemotherapeutics, targeted toxins, genetic and viral therapies in neuro-oncology

artículo científico publicado en 2004

Objective determination of the oncolytic potency of conditionally-replicating adenoviruses using mathematical modeling.

artículo científico publicado en 2010

Quantification of nanosized extracellular membrane vesicles with scanning ion occlusion sensing

artículo científico publicado en 2013

Serum-free culture success of glial tumors is related to specific molecular profiles and expression of extracellular matrix-associated gene modules.

artículo científico

Sitimagene ceradenovec: a gene-based drug for the treatment of operable high-grade glioma

artículo científico publicado en 2010

The HDAC Inhibitors Scriptaid and LBH589 Combined with the Oncolytic Virus Delta24-RGD Exert Enhanced Anti-Tumor Efficacy in Patient-Derived Glioblastoma Cells

artículo científico publicado en 2015

The in vivo therapeutic efficacy of the oncolytic adenovirus Delta24-RGD is mediated by tumor-specific immunity

artículo científico publicado en 2014

The organotypic multicellular spheroid is a relevant three-dimensional model to study adenovirus replication and penetration in human tumors in vitro

artículo científico publicado en 2002

The therapeutic efficacy of the oncolytic virus Delta24-RGD in a murine glioma model depends primarily on antitumor immunity.

artículo científico publicado en 2014

Tissue inhibitor of metalloproteinase-3 expression from an oncolytic adenovirus inhibits matrix metalloproteinase activity in vivo without affecting antitumor efficacy in malignant glioma.

artículo científico publicado en 2005

Truncating the i-leader open reading frame enhances release of human adenovirus type 5 in glioma cells

artículo científico publicado en 2011

Lista de obras de Martine Lamfers

ABT-888 enhances cytotoxic effects of temozolomide independent of MGMT status in serum free cultured glioma cells.

AdDelta24 and the p53-expressing variant AdDelta24-p53 achieve potent anti-tumor activity in glioma when combined with radiotherapy.

Adenoviral delivery of a constitutively active retinoblastoma mutant inhibits neointima formation in a human explant model for vein graft disease

Adenoviral expression of a urokinase receptor-targeted protease inhibitor inhibits neointima formation in murine and human blood vessels.

Anatomical differences determine distribution of adenovirus after convection-enhanced delivery to the rat brain

Characterization of infectivity of knob-modified adenoviral vectors in glioma.

Complement activation in Glioblastoma multiforme pathophysiology: evidence from serum levels and presence of complement activation products in tumor tissue

Conditionally replicative adenovirus expressing a targeting adapter molecule exhibits enhanced oncolytic potency on CAR-deficient tumors.

Coronavirus genetically redirected to the epidermal growth factor receptor exhibits effective antitumor activity against a malignant glioblastoma

Cyclophosphamide increases transgene expression mediated by an oncolytic adenovirus in glioma-bearing mice monitored by bioluminescence imaging

DNA Methylation and Somatic Mutations Converge on the Cell Cycle and Define Similar Evolutionary Histories in Brain Tumors

DNA damage response and anti-apoptotic proteins predict radiosensitization efficacy of HDAC inhibitors SAHA and LBH589 in patient-derived glioblastoma cells.

Delta-24-RGD oncolytic adenovirus elicits anti-glioma immunity in an immunocompetent mouse model

Differential effects of combined Ad5- delta 24RGD and radiation therapy in in vitro versus in vivo models of malignant glioma.

Distinguishing inflammation from tumor and peritumoral edema by myeloperoxidase magnetic resonance imaging.

Establishing the Lysine-rich Protein CEST Reporter Gene as a CEST MR Imaging Detector for Oncolytic Virotherapy

Evaluation of adenoviral oncolytic effect on glioma spheroids by 18F-DG positron-emission tomography

Evolution of DNA repair defects during malignant progression of low-grade gliomas after temozolomide treatment

Evolving gene therapy approaches for osteosarcoma using viral vectors: review

Gene delivery into malignant glioma by infectivity-enhanced adenovirus: in vivo versus in vitro models

Gene therapy for meningioma: improved gene delivery with targeted adenoviruses

Gene transfer of the urokinase-type plasminogen activator receptor-targeted matrix metalloproteinase inhibitor TIMP-1.ATF suppresses neointima formation more efficiently than tissue inhibitor of metalloproteinase-1.

Generation, characterization, and drug sensitivities of 12 patient-derived IDH1-mutant glioma cell cultures

Genetic biomarkers of drug response for small-molecule therapeutics targeting the RTK/Ras/PI3K, p53 or Rb pathway in glioblastoma.

Glioblastoma-derived extracellular vesicles modify the phenotype of monocytic cells.

Heterogeneous reovirus susceptibility in human glioblastoma stem-like cell cultures.

Histone deacetylase inhibitors upregulate expression of the coxsackie adenovirus receptor (CAR) preferentially in bladder cancer cells

Homing properties of adipose-derived stem cells to intracerebral glioma and the effects of adenovirus infection

IDH1 R132H decreases proliferation of glioma cell lines in vitro and in vivo

In vitro screening of clinical drugs identifies sensitizers of oncolytic viral therapy in glioblastoma stem-like cells.

In vivo suppression of restenosis in balloon-injured rat carotid artery by adenovirus-mediated gene transfer of the cell surface-directed plasmin inhibitor ATF.BPTI.

Locally-delivered T-cell-derived cellular vehicles efficiently track and deliver adenovirus delta24-RGD to infiltrating glioma

Neurosurgical delivery of chemotherapeutics, targeted toxins, genetic and viral therapies in neuro-oncology

Objective determination of the oncolytic potency of conditionally-replicating adenoviruses using mathematical modeling.

Quantification of nanosized extracellular membrane vesicles with scanning ion occlusion sensing

Serum-free culture success of glial tumors is related to specific molecular profiles and expression of extracellular matrix-associated gene modules.

Sitimagene ceradenovec: a gene-based drug for the treatment of operable high-grade glioma

The HDAC Inhibitors Scriptaid and LBH589 Combined with the Oncolytic Virus Delta24-RGD Exert Enhanced Anti-Tumor Efficacy in Patient-Derived Glioblastoma Cells

The in vivo therapeutic efficacy of the oncolytic adenovirus Delta24-RGD is mediated by tumor-specific immunity

The organotypic multicellular spheroid is a relevant three-dimensional model to study adenovirus replication and penetration in human tumors in vitro

The therapeutic efficacy of the oncolytic virus Delta24-RGD in a murine glioma model depends primarily on antitumor immunity.

Tissue inhibitor of metalloproteinase-3 expression from an oncolytic adenovirus inhibits matrix metalloproteinase activity in vivo without affecting antitumor efficacy in malignant glioma.

Truncating the i-leader open reading frame enhances release of human adenovirus type 5 in glioma cells